CyberKnife Stereotactic Radiosurgery
CyberKnife and Cancer Treatment
You have new interventions for treating bone, lung, liver and brain metastases. When medical therapies are controlling your cancer outside of a few areas, consider CyberKnife, a revolutionary stereotactic radiation tool in cancer treatment. CyberKnife is used to treat primary and metastatic cancers by precisely targeting the tumor, adjusting robotically in real time to tumor or patient movement. Published data shows exceptional outcomes, fewer side effects, and short treatment courses - leading to a better quality of life, during and after treatment.
Evaluation of patients with one to five "oligo"-metastatic sites in the "COMET" trial demonstrated meaningful improvements in progression free and overall survival with stereotactic radiation of metastatic disease. COMET trial: https://pubmed.ncbi.nlm.nih.gov/31426760/
Call 206-320-7187 to speak with us about CyberKnife.
CyberKnife is the world's first and only robotic radiosurgery system accurate enough to target small and complex tumors anywhere in the body. Stereotactic radiosurgery, despite its name, is a non-surgical procedure and that uses precisely targeted radiation.
It is a safe alternative to surgery and uses a high-energy x-ray machine on a robotic arm to deliver the radiation beams. The Swedish Radiosurgery Center treats patients with cancerous and non-cancerous tumors anywhere in the body.
Real time patient monitoring allows for accurate dose delivery to the target area with minimal exposure to surrounding healthy tissue. This is particularly beneficial in the treatment of lung, breast, liver, pancreas, kidney and other abdominal or thoracic tumors that move when the patient breathes.
CyberKnife Benefits
- Preserves healthy tissue surrounding the target area
- Real time tumor tracking
- Non-invasive procedure
- No general anesthesia
- Outpatient procedure
- Few, if any, side effects
Learn how CyberKnife works
Learn about the Treatment Process